Cheetah Medical, Inc.: Series B $20M

Posted in I - Series B, Q - 1Q10, R - INTERNATIONAL, X - Device (Cardiology)

Cheetah Medical (Israel) a commercial-stage device company focused on non-invasive cardiac output and hemodynamic monitoring, closed a $20M Series B financing. Participants include Ascension Health Ventures, Robert Bosch Venture Capital and MVM Life Science Partners.

Jan

2010

BioVex, Inc.: Series F $30M

Posted in I - Series F, Q - 4Q09, R - NORTH EAST, X - Biologics Mfg., X - Oncology, XX - MA

BioVex (Woburn, MA) a clinical-stage biologics company focused on metastatic melanoma, head and neck, pancreatic and colo-rectal cancer, closed a $30M Series F bringing the entire round to $70M. Participants have included Morningside Venture, Ventech, MVM Life Science Partners, Sectoral Asset Management, Ysios Capital Partners, Forbion Capital Partners, Credit Agricole Private Equity, Harris & Harris [...]

Jan

2010

Tarsa Therapeutics, Inc.: Series A $24M

Posted in I - Series A, Q - 4Q09, R - NORTH EAST, X - Osteoporosis, XX - NJ

Tarsa Therapeutics (Boonton, NJ) a clinical stage small molecule company focused on osteoporosis closed a $24M Series A financing. Participants include MVM Life Science Partners, Quaker BioVentures and Novo Ventures.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

to top of page...